The Epidemic of Cardiovascular Disease in the Developing World: Global Implications
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, December 9, 2010
Forchheimer 1st Floor Lecture Hall, Einstein
Cherhasky Auditorium, Montefiore
Bernard J. Gersh, MB, ChB, DPhil
Bernard J. Gersh, MB, ChB, DPhil
Professor of Medicine, Mayo Clinic College of Medicine
Consultant in Cardiovascular Diseases and Internal Medicine
Associate Chair of Academic Affairs and Faculty Development
Division of Cardiovascular Diseases
Medical Grand Rounds this week is the James Scheuer Lectureship, supported by Dr. James Scheuer, Emeritus Professor and Emeritus Chair of Medicine at Einstein/Montefiore, and by the Division of Cardiology.
Dr. Bernard Gersh’s wide interests include the natural history and therapy of acute and chronic coronary artery disease; clinical electrophysiology, and in particular atrial fibrillation and sudden cardiac death; the cardiomyopathies and the clinical implications of molecular genetics in hypertrophic cardiomopathy; cardiac stem cell therapy; and the epidemiology of cardiovascular disease in the developing world.
Dr. Gersh has authored or co-authored 657 articles and 125 book chapters. Dr. Gersh is the editor of 11 books and is on the editorial board of 25 journals including Circulation, Journal of the American College of Cardiology (Senior Consulting Editor), Nature Cardiovascular Medicine, and The European Heart Journal (2009 Deputy Editor). He is a member of the Advisory Board of the Reynolds Foundation, a Past Chairman of the Council of Clinical Cardiology of the American Heart Association, and a former Member of the Board of Trustees of the American College of Cardiology. He has served on the Steering Committees and Data Safety Monitoring Boards of multiple clinical trials, sponsored by the National Lung and Blood Institute and other organizations. He is currently Chairman of the WHO Cardiovascular Working Group on ICD 11 Reclassification.
Dr. Gersh’s honors include Teacher of the Year Award from the Division of Cardiovascular Diseases at the Mayo Clinic, and numerous Visiting Professorships and Invited Lectures both nationally and internationally, including the 2009 Henry Russek American College of Cardiology lecture, the Rene Laennec Invited Lecture and Silver Medal of the 2010 European Society of Cardiology, and the Hatter Award for “Advancement in the Cardiovascular Science” from the University College London and the University of Cape Town. He is an Honorary Member of the South African Cardiac Society and The South African Heart Association, and he is an Honorary Fellow of the Sociedad Chilena De Cardiologia Y Cirugia Cardiovascular. He is an Honorary Professor of Medicine at the University of Cape Town, South Africa, and received the degree of Ph.D. (honoris causa) from The University of Coimbra, Portugal in 2005.
Dr. Gersh was the 2004 recipient of the Distinguished Achievement Award of the AHA Council of Clinical Cardiology and the 2007 recipient of the ACC Distinguished Service Award. He is the Rene Laennec lecturer at the European Society of Cardiology in 2010 and will receive the Silver Medal of the Society.
Dr. Gersh's past positions include The W. Proctor Harvey Teaching Professor of Cardiology and Chief of the Division of Cardiology at Georgetown University Medical Center.
Dr. Gersh received his MB, ChB, from the University of Cape Town in South Africa. He received his Doctor of Philosophy Degree from Oxford University, where he was a Rhodes Scholar. He is a Fellow of the South African College of Physicians and of the Royal College of Physicians in the United Kingdom, as well as a Fellow of the American College of Cardiology and the American Heart Association.
After attending this activity, participants will be able to:
- Emphasize the magnitude of the epidemic of CVD in the developing world
- Clarify the concept of the "epidemiologic transition"
- Discuss the role of traditional and 'novel' risk factors in the epidemiology of CVD in the developing world
- Highlight different strategies for disease prevention
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.